You just read:

Vanda Receives Positive CHMP Opinion for HETLIOZ® (tasimelteon) for the Treatment of Non-24-Hour Sleep-Wake Disorder in the European Union

News provided by

Vanda Pharmaceuticals Inc.

24 Apr, 2015, 14:32 BST